[Federal Register Volume 86, Number 82 (Friday, April 30, 2021)]
[Notices]
[Page 22970]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-09043]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2014-N-0345]


Agency Information Collection Activities; Announcement of Office 
of Management and Budget Approval; Data to Support Drug Product 
Communications

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA or Agency) is announcing 
that a collection of information entitled ``Data to Support Drug 
Product Communications'' has been approved by the Office of Management 
and Budget (OMB) under the Paperwork Reduction Act of 1995 (PRA).

FOR FURTHER INFORMATION CONTACT: Ila S. Mizrachi, Office of Operations, 
Food and Drug Administration, Three White Flint North, 10A-12M, 11601 
Landsdown St., North Bethesda, MD 20852, 301-796-7726, 
PRAStaff@fda.hhs.gov.

SUPPLEMENTARY INFORMATION: On February 2, 2020, the Agency submitted a 
proposed collection of information entitled ``Data to Support Drug 
Product Communications'' to OMB for review and clearance under 44 
U.S.C. 3507. An Agency may not conduct or sponsor, and a person is not 
required to respond to, a collection of information unless it displays 
a currently valid OMB control number. OMB has now approved the 
information collection and has assigned OMB control number 0910-0695. 
The approval expires on March 31, 2024. A copy of the supporting 
statement for this information collection is available on the internet 
at https://www.reginfo.gov/public/do/PRAMain.

    Dated: April 26, 2021.
Lauren K. Roth,
Acting Principal Associate Commissioner for Policy.
[FR Doc. 2021-09043 Filed 4-29-21; 8:45 am]
BILLING CODE 4164-01-P


